Alpix Shares Early Beta Insights on AI-Assisted Trading and On-Chain Perpetuals Platform 
Heavyweight Endorsement from Top-tier Cornerstone Investors! Sigenergy (06656.HK) Launches IPO: Led by Temasek and Goldman Sachs, the AI Energy Storage Leader Ignites Hong Kong’s New Stock Frenzy 
Shoucheng Holdings (0697.HK) Combines Dividends and Share Buybacks in Tandem, Returning Approximately HK$6.877 Billion to Shareholders Over Eight Years 
Formerra Announces Global Price Increase 
U.S. Polo Assn. and ESPN Champion the Iconic USPA Gold Cup at the USPA National Polo Center, Hosted by Legendary Commentator Chris Fowler Peach Finance Joins Mastercard Engage Partner Network to Help Lenders Develop Installments Solutions
OAKLAND, Calif.–(BUSINESS WIRE)–#lending–Peach Finance, the leading modern loan management and servicing technology platform, today announced…
IntelePeer Enhances Platform Security, Achieving SOC 2 Type 2 Certification
Continued certification affirms IntelePeer’s commitment to policies, procedures and operations that meet SOC 2 Type…
Mindbreeze’s Five Trends 2023: The Focus is on the Sustainable Use of Information
CHICAGO–(BUSINESS WIRE)–In view of the current challenges, there is hardly a topic that has gained…
New Survey from Privitar and Bloor Research Reveals a Majority of Data Leaders Unable to Use More than 40% of Their Data Due to Security and Privacy Concerns
Data Privacy, Compliance, and Data Access Control Among Top Challenges Hindering Organizations Ability to Effectively…
Rentschler implements innovative learning program in collaboration with MassBioEd and WPI
Program trains people returning to the workforce for biotech manufacturing positions LAUPHEIM, Germany and MILFORD,…
BioCorRx Partners with Government Plus to Expand its Beat Addiction Recovery Program in the United States
ANAHEIM, CA, Dec. 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a…
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) — ADMA Biologics, Inc….
X4 Pharmaceuticals Prices $65.0 Million Public Offering
BOSTON, Dec. 07, 2022 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in…
SciSparc Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy
The non- clinical study was conducted at The Chaim Sheba Medical Center in Israel Tel-Aviv,…
Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million
Proceeds extend cash runway to fund operations into early 2024 Carlsbad, CA, Dec. 07, 2022 (GLOBE…
IGC Applauds Signing of Bipartisan Medical Marijuana and Cannabidiol Research Expansion Act
POTOMAC, Md., Dec. 07, 2022 (GLOBE NEWSWIRE) — via InvestorWire — India Globalization Capital, Inc…
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
— Amarin Continuing Process for Obtaining National Pricing and Reimbursement in Switzerland in the Course…
VYNE Therapeutics Announces First Patent Granted for Novel BET Inhibitor Platform
Newly issued patent expires in 2040 BRIDGEWATER, N.J., Dec. 07, 2022 (GLOBE NEWSWIRE) — VYNE…
Ocugen Announces Update on OCU400 Phase 1/2 Clinical Trial Targeting Retinitis Pigmentosa and Leber Congenital Amaurosis
Continued Positive Safety Data for OCU400 Established High Dose as the Maximum Tolerable Dose in…
BetterLife Announces Closing of Private Placement
VANCOUVER, British Columbia, Dec. 07, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Piiano Equips Developers to Stop Sensitive Data Breaches
Data protection company Piiano officially launches a vault for sensitive customer data, the first among…
RIGImmune Announces New Funding to Advance Development of RNA Virus Treatments
Program-Related Investment and Grant from the Bill & Melinda Gates Foundation to advance RIGImmune’s RNA…
PepGen Announces IND-Enabling Preclinical Data Supporting Progression of PGN-EDODM1 into Clinical Studies
DMPK Transcript Levels Figure 1. No significant changes in mean DMPK transcript levels were observed…
Cerevance to Present at the RBC Capital Markets Virtual Healthcare Private Company Conference
BOSTON, Dec. 07, 2022 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
BioVie Issues Letter to Shareholders
Parkinson’s disease (PD) patients treated with NE3107 for 28 days experienced a clinically meaningful increase…